Sponsor or institution
Clinical trials and research at New York University D/b/a NYU Long Island School of Medicine
As of November 12, 2026, Find a Trial lists 11 NIH-funded research projects at this institution, with $7.3 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 11NIH research projects
NIH-funded research (11)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
NYU Coordinating Center for CASSIDY supports diabetes surveillance in youth
A national network is building better ways to track diabetes in kids and young adults using electronic health records, and NYU’s coordinating center helps organize data, methods, and governance.
-
Regulation of blood cholesterol by a tiny RNA
A scientist team is studying how a small molecule called microRNA-541-3p controls levels of LDL and HDL cholesterol, with potential implications for heart disease.
-
Blood vessel lipids and how they shape artery health
Aimed at understanding how blood lipids move into artery walls and influence atherosclerosis, with a focus on endothelial cells and tiny lipid carriers.
-
Understanding how the liver controls apoB-containing lipoproteins that may raise heart disease risk
Researchers are studying how the liver makes apoB-containing lipoproteins like VLDL and how fat and lipolysis signaling influence this process to better prevent atherosclerotic disease.
-
Adipose MTP and FIT2: how fat tissue controls cholesterol, obesity, and heart disease
A research team at NYU Langone studies how fat tissue proteins MTP and FIT2 influence cholesterol levels, obesity, and atherosclerosis in order to find new ways to prevent heart disease.
-
Atherosclerosis Core for analyzing artery lesions and immune cells
A central NYU Langone/LONG ISLAND check-in provides expert tissue analysis and gene data to researchers studying how arteries harden and why immune cells contribute to the disease.
-
Human Tissues, Lipoproteins, Lipidomics, and Proteomics Core for Cardiovascular Research
A core facility at NYU Langone/Long Island will provide human tissues and advanced lipid/proteomics analyses to support cardiovascular research across three projects.
-
Biostatistics and Bioinformatics Core for patient-centered research
A dedicated Biostatistics and Bioinformatics Core will help multiple projects collect, manage, and analyze data to improve understanding of atherogenic and metabolic processes.
-
Understanding how the body makes and clears lipoproteins that raise heart disease risk
This grant studies how liver-produced apoB-containing lipoproteins are formed and broken down, with the goal of lowering factors that raise cardiovascular risk in people.
-
How the body‑clock gene Bmal1 controls cholesterol handling in immune cells
The team is working to understand how the body clock gene Bmal1 changes how immune cells handle cholesterol, which could matter for people at risk for artery plaque and heart disease.
-
How the liver protein RXRα controls PCSK9 and cholesterol levels
This research is testing whether boosting a liver protein called RXRα can lower PCSK9 and reduce LDL (bad) cholesterol for people with fatty liver disease or atherosclerotic heart disease.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.